Menu

Centessa Pharmaceuticals plc CNTA

Full chart Compare
Set alert

Price alert · CNTA

All alert types
40.50 USD 0.00 (+0.00%)

At closeJun 25, 2026, 4:00 PM EDT

40.68 +0.18 +0.45%

After hours · Jun 25, 4:00 PM ET

40.50 Day range 40.50

52-week range unavailable

YTD
+61.94%
1 year
+201.56%

Revenue & Expenses

Other Income → Expenses: $11.98MExpenses → Selling, General & Admin: $50.47MExpenses → Research & Development: $172.22MExpenses → Income Tax: $1.82MGross Profit → Expenses: $15.00MRevenue → Gross Profit: $15.00MNet Loss → Expenses: $197.53MOther Income$11.98MGross Profit$15.00MNet Loss$197.53MExpenses$224.51MSelling, General & Admin$50.47MResearch & Development$172.22MIncome Tax$1.82MRevenue$15.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CNTA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
15.00M06.85M00
15.00M06.85M00
-207.69M-201.06M-171.28M-209.92M-378.45M
-197.53M-235.76M-151.09M-216.21M-381.07M
-1.46-2.06-1.57-2.31-5.07
CNTA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
61.30M383.22M128.03M393.64M595.08M
687.50M576.80M360.25M444.31M629.63M
160.63M175.25M124.00M108.14M138.08M
117.67M117.23M84.59M69.80M75.70M
526.86M401.55M236.24M336.17M491.55M
CNTA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-193.82M-142.06M-160.34M-200.55M-135.11M
-418.53M31.27M-127.00M-931.00K63.26M
291.53M364.75M21.12M457.00K660.15M
-371.00K-34.00K-169.00K-1.14M-186.00K
-321.27M255.19M-265.61M-201.44M590.12M